Biocon Boosts Biosimilars In Australia With Sandoz Partnership
Five-Year Exclusive Marketing Deal Will Cover Indian Firm’s Trastuzumab And Bevacizumab
• By David Wallace
Biocon and Sandoz have struck a biosimilars deal in Australia • Source: Shutterstock 
